251 related articles for article (PubMed ID: 10412300)
1. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
Wiboltt K; Raskov HH
Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
[TBL] [Abstract][Full Text] [Related]
2. [Treatment with cytostatic agents should be considered in colorectal cancer. It improves prognosis and quality of life].
Larsson PA
Lakartidningen; 1999 May; 96(19):2314-6. PubMed ID: 10377671
[No Abstract] [Full Text] [Related]
3. [Palliative treatment with cytostatics of metastatic colorectal cancer in general practice. A model].
Skylstad D; Sørbye H; Småland R
Tidsskr Nor Laegeforen; 1997 Nov; 117(27):3969-72. PubMed ID: 9441425
[TBL] [Abstract][Full Text] [Related]
4. [Palliative chemotherapy in colorectal cancer--can we afford it?].
Kronborg O
Ugeskr Laeger; 1999 Jun; 161(25):3815. PubMed ID: 10412296
[No Abstract] [Full Text] [Related]
5. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
6. Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinoma.
Grem JL; Shoemaker DD; Petrelli NJ; Douglass HO
Cancer Treat Rep; 1987 Nov; 71(11):1122. PubMed ID: 3499982
[No Abstract] [Full Text] [Related]
7. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
[TBL] [Abstract][Full Text] [Related]
8. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
[No Abstract] [Full Text] [Related]
9. [Adjuvant therapy for colon cancer].
Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
[No Abstract] [Full Text] [Related]
10. [Surgery and multidisciplinary treatment for colorectal cancer].
Sakamoto J; Kato J; Yasue M
Gan To Kagaku Ryoho; 1998 Jan; 25(2):208-15. PubMed ID: 9474930
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of m-FOLFOX6 therapy for colorectal cancer in elderly patients].
Young Kim W; Maeda K; Noda E; Fukunaga S; Inoue T; Kaizaki R; Shinto O; Wada K; Nakano T; Hirakawa K
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1833-6. PubMed ID: 18030018
[TBL] [Abstract][Full Text] [Related]
12. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
[TBL] [Abstract][Full Text] [Related]
13. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
[No Abstract] [Full Text] [Related]
14. [Choice of treatment in rectal cancer. Consensus Conference, Chamber of Commerce and Industry, Paris, December 1-2, 1994].
Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):226-30, 233-6. PubMed ID: 7486820
[No Abstract] [Full Text] [Related]
15. Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
Burch PA; Block M; Schroeder G; Kugler JW; Sargent DJ; Braich TA; Mailliard JA; Michalak JC; Hatfield AK; Wright K; Kuross SA
Clin Cancer Res; 2000 Sep; 6(9):3486-92. PubMed ID: 10999733
[TBL] [Abstract][Full Text] [Related]
16. [An institution-randomized trial of 5-fluorouracil and l-leucovorin therapy given monthly versus every two months to patients with advanced colorectal carcinoma].
Hasegawa S; Akaike M; Yamamoto Y; Shiraishi R; Ozawa Y; Suzuki H; Miyazaki T; Kasahara A; Makino T; Tamura I; Tanabe H; Rino Y
Gan To Kagaku Ryoho; 2004 May; 31(5):729-33. PubMed ID: 15170981
[TBL] [Abstract][Full Text] [Related]
17. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
Uemura N; Yamada Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
[TBL] [Abstract][Full Text] [Related]
18. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
Fritz P; Stoll P; Wannenmacher M; Zierhut D
Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
[TBL] [Abstract][Full Text] [Related]
20. [Epiphora in a patient receiving FOLFOX therapy].
Yatsuda C; Niimi M; Ono Y; Uto N; Iwagami E; Tanaka E; Yamato M
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1989-91. PubMed ID: 19011359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
